Literature DB >> 15578297

Evidence of small-bowel involvement in hereditary hemorrhagic telangiectasia: a capsule-endoscopic study.

M Ingrosso1, C Sabbà, A Pisani, M Principi, M Gallitelli, A Cirulli, A Francavilla.   

Abstract

BACKGROUND AND STUDY AIMS: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant vascular disorder leading to telangiectases and arteriovenous malformations of the skin, mucosa, and viscera. Telangiectases in the upper gastrointestinal tract are known, but data regarding possible small-bowel involvement are scarce due to the technical difficulty of exploring the entire gastrointestinal tract. The aim of the present study was to use capsule endoscopy (CE) to determine the prevalence of small-bowel telangiectases in HHT patients. PATIENTS AND METHODS: From December 2001 to September 2002, 20 consecutive adult HHT patients at an interdepartmental HHT center were prospectively evaluated. All patients underwent esophagogastroduodenoscopy (EGD) followed by CE within 24 h. The telangiectases were scored according to commonly accepted criteria by two endoscopists and two observers of the video-capsule images, who were blinded to each other's findings.
RESULTS: EGD revealed gastric telangiectases in 15 of the 20 patients (75 %), while CE demonstrated small-bowel involvement in 10 of 18 patients (56 %; images were not recorded for two patients due to battery failure). No preferential site for telangiectasia was found between the jejunum and the terminal ileum. All patients who were positive on CE were also found to have gastric involvement at EGD. Patients with small-bowel telangiectases were significantly older than those without (62.5 years vs. 45 years; P < 0.02).
CONCLUSIONS: This study established a 56 % prevalence of small-bowel telangiectases in patients with HHT. This new endoscopic technique will probably change the etiological diagnosis of occult bleeding in HHT patients (which is too often attributed only to epistaxis) and may also be able to alter treatment strategies in HHT patients with gastrointestinal bleeding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578297     DOI: 10.1055/s-2004-826045

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  13 in total

1.  Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia.

Authors:  Lino Polese; Imerio Angriman; Duilio Pagano; Maria L Tenderini; Francesca Polese; Mauro Frego; Davide F D'Amico; Lorenzo Norberto
Journal:  Lasers Med Sci       Date:  2006-07-29       Impact factor: 3.161

2.  Surgical treatment of gastrointestinal hereditary hemorrhagic telangiectasia.

Authors:  Min-Hsuan Yen; Chiung-Nien Chen
Journal:  Acute Med Surg       Date:  2015-11-12

Review 3.  Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.

Authors:  Samuel B Jackson; Nicholas P Villano; Jihane N Benhammou; Michael Lewis; Joseph R Pisegna; David Padua
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

4.  Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease.

Authors:  Carlos Bernardes; Sara Santos; Rafaela Loureiro; Verónica Borges; Gonçalo Ramos
Journal:  GE Port J Gastroenterol       Date:  2017-10-05

5.  Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

Authors:  Jan Lerut; Giuseppe Orlando; René Adam; Carlo Sabbà; Robert Pfitzmann; Jurgen Klempnauer; Jacques Belghiti; Jacques Pirenne; Thierry Thevenot; Christian Hillert; Colin M Brown; Dominique Gonze; Vincent Karam; Olivier Boillot
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

Review 6.  Optimal management of hereditary hemorrhagic telangiectasia.

Authors:  Neetika Garg; Monica Khunger; Arjun Gupta; Nilay Kumar
Journal:  J Blood Med       Date:  2014-10-15

Review 7.  Rendu-Osler-Weber disease: a gastroenterologist's perspective.

Authors:  Annalisa Tortora; Maria Elena Riccioni; Eleonora Gaetani; Veronica Ojetti; Grainne Holleran; Antonio Gasbarrini
Journal:  Orphanet J Rare Dis       Date:  2019-06-07       Impact factor: 4.123

8.  Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.

Authors:  Marie E Faughnan; James R Gossage; Murali M Chakinala; S Paul Oh; Raj Kasthuri; Christopher C W Hughes; Justin P McWilliams; Joseph G Parambil; Nicholas Vozoris; Jill Donaldson; Gitanjali Paul; Pamela Berry; Dennis L Sprecher
Journal:  Angiogenesis       Date:  2018-09-06       Impact factor: 9.596

9.  Dyspnea with anemia turned out to be a case of hereditary hemorrhagic telangiectasia.

Authors:  Amitabha Sengupta; Kaushik Saha; Debraj Jash; Sourindra N Banerjee
Journal:  Asian J Transfus Sci       Date:  2013-01

10.  The Impact of Small Bowel Endoscopy in Patients with Hereditary Hemorrhagic Telangiectasia

Authors:  Stefania Chetcuti Zammit; David S. Sanders; Mark E. McAlindon; Reena Sidhu
Journal:  Turk J Haematol       Date:  2018-07-24       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.